CSID Leadership Summit at Gastro Health Newsletter
To claim 1.0 AMA PRA Category 1 Credit™ for this activity, please visit:
Release date: February 22, 2024
Expiration date: February 22, 2025
Target Audience
This initiative will attract an audience of health care professionals (HCPs), including gastroenterologists, nurse practitioners, physician assistants and allied health HCPs.
Program Overview
The summit will bring together three expert advisors and more than 20 gastroenterologists and advanced practice providers (APPs) to focus on functional GI and motility disorders to develop topic-specific content addressing the educational needs of health care providers managing CSID. Faculty members will collaborate with participants for a deep dive across all aspects of CSID management. The proceedings will be recorded, along with all available data and recommendations, and an educational newsletter developed.
Educational Objectives
Upon completion of this activity, participants should be able to:
-
Describe the prevalence of CSID in patients with common GI disorders
-
Incorporate current diagnostic strategies to differentiate CSID from other causes of persistent diarrhea seen in clinical practice, particularly among patients with suspected IBS
-
Summarize benefits and limitations of current treatment strategies for CSID
Faculty
Brooks Cash, MD
Daksesh Patel, DO
Kaitlin Colella, PA-C
Julie Messick, PharmD
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Gi Health Foundation. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team..
Physician Credit
Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, the Gi Health Foundation, and/or QOL Medical LLC. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
There is no fee for this educational activity.
This activity is jointly provided by Medical Education Resources and the Gi Health Foundation.
Supported by an educational grant from QOL Medical LLC.
